Cardio Diagnostics to Unveil Non-Obstructive Coronary Artery Disease Data, FDA Breakthrough Device Designation Strategy, and India Launch Update on December 10 Investor Call
CHICAGO--(BUSINESS WIRE)--Cardio Diagnostics Holdings, Inc. will host an investor
conference call on Thursday, December 10, 2026, at 11 a.m. Central Time.